"Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms
- PMID: 12842424
- DOI: 10.1016/s1525-0016(03)00151-5
"Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms
Abstract
It has been suggested that several proteins, termed "translocatory" or "messenger" proteins, can move between living cells-exiting the cell of synthesis via an uncharacterized secretory pathway and entering adjacent cells by a nonendocytic mechanism that is active even at 4 degrees C. These activities, which have been mapped to short, highly basic regions termed "protein transduction domains" (PTDs), have engendered considerable interest in the gene therapy and vaccine research communities. If these proteins, and PTDs, are to be used in human or veterinary medicine, it is vital that the mechanisms underlying their effects be understood. This article presents a critical evaluation of the current literature and describes recent findings that indicate that the effects of these sequences might be explained by well-established biological principles.
Similar articles
-
Biological applications of protein transduction technology.Trends Biotechnol. 2003 Nov;21(11):498-503. doi: 10.1016/j.tibtech.2003.09.008. Trends Biotechnol. 2003. PMID: 14573363 Free PMC article. Review.
-
Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo.Mol Ther. 2003 Jul;8(1):130-42. doi: 10.1016/s1525-0016(03)00131-x. Mol Ther. 2003. PMID: 12842436
-
Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity.Gene Ther. 2002 Nov;9(21):1422-8. doi: 10.1038/sj.gt.3301819. Gene Ther. 2002. PMID: 12378404
-
New transport peptides broaden the horizon of applications for peptidic pharmaceuticals.Mol Divers. 2004;8(2):101-11. doi: 10.1023/b:modi.0000025653.26130.ce. Mol Divers. 2004. PMID: 15209161
-
[Protein transduction and protection of cells against apoptosis].Seikagaku. 2004 Jul;76(7):654-8. Seikagaku. 2004. PMID: 15346902 Review. Japanese. No abstract available.
Cited by
-
The taming of the cell penetrating domain of the HIV Tat: myths and realities.J Control Release. 2007 Feb 12;117(2):148-62. doi: 10.1016/j.jconrel.2006.10.031. Epub 2006 Nov 17. J Control Release. 2007. PMID: 17196289 Free PMC article. Review.
-
SNAP-23 and syntaxin-2 localize to the extracellular surface of the platelet plasma membrane.Blood. 2007 Sep 1;110(5):1492-501. doi: 10.1182/blood-2006-11-055772. Epub 2007 May 7. Blood. 2007. PMID: 17485553 Free PMC article. Clinical Trial.
-
Free energy of translocating an arginine-rich cell-penetrating peptide across a lipid bilayer suggests pore formation.Biophys J. 2013 Jan 22;104(2):412-20. doi: 10.1016/j.bpj.2012.10.027. Biophys J. 2013. PMID: 23442863 Free PMC article.
-
Analysis of the selective advantage conferred by a C-E1 fusion protein synthesized by rubella virus DI RNAs.Virology. 2007 Dec 5;369(1):19-34. doi: 10.1016/j.virol.2007.06.047. Epub 2007 Aug 15. Virology. 2007. PMID: 17698161 Free PMC article.
-
Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.Genet Vaccines Ther. 2005 Apr 20;3(1):3. doi: 10.1186/1479-0556-3-3. Genet Vaccines Ther. 2005. PMID: 15842732 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources